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The Role of Diffusion-Weighted Imaging
and the Apparent Diffusion Coefficient
(ADC) Values for Breast Tumors
Objective: We wanted to evaluate the role of diffusion-weighted imaging (DWI)
and the apparent diffusion coefficient (ADC) for detecting breast tumors, as com-
pared with the T1- and T2-weighted images.
Materials and Methods: Forty-one female patients underwent breast MRI, and
this included the T1-, T2-, DWI and dynamic contrast-enhanced images. Sixty-
five enhancing lesions were detected on the dynamic contrast-enhanced images
and we used this as a reference image for detecting tumor. Fifty-six breast
lesions were detected on DWI and the histological diagnoses were as follows: 43
invasive ductal carcinomas, one mucinous carcinoma, one mixed infiltrative and
mucinous carcinoma, seven ductal carcinomas in situ (DCIS), and four benign
tumors. First, we compared the detectability of breast lesions on DWI with that of
the T1- and T2-weighted images. We then compared the ADCs of the malignant
and benign breast lesions to the ADCs of the normal fibroglandular tissue. 
Results: Fifty-six lesions were detected via DWI (detectability of 86.2%). The
detectabilities of breast lesions on the T1- and T2-weighted imaging were 61.5%
(40/65) and 75.4% (49/65), respectively. The mean ADCs of the invasive ductal
carcinoma (0.89  0.18 10
3mm
2/second) and DCIS (1.17  0.18 10
3mm
2/
second) are significantly lower than those of the benign lesions (1.41  0.56
10
3mm
2/second) and the normal fibroglandular tissue (1.51  0.29 10
3mm
2/
second). 
Conclusion: DWI has a high sensitivity for detecting breast tumors, and espe-
cially for detecting malignant breast tumors. DWI was an effective imaging tech-
nique for detecting breast lesions, as compared to using the T1- and T2-weighted
images.
iffusion is the result of thermal fluctuations with a random pattern and
this is often referred to as “Brownian motion” (1 3). Diffusion-weighted
imaging (DWI) is the primary modality that’s used to evaluate acute
cerebral infarction. DWI has recently been widely used to evaluate other organs such
as the ovaries, pancreas, prostate, liver and breast (2 10). Until now, there have been
few reports published about using the DWI technique to detect and characterize breast
tumors, and especially malignant breast tumor (2 5). 
Breast MRI has widely used for the detection, diagnosis and staging of breast cancer
(11 14). T1- and T2-weighted images are routinely performed before dynamic
contrast-enhanced imaging. Although the T1- and T2-weighted images can show a
tumor’s structure and the tissue component, these modalities have some limitations for
detecting and characterizing breast lesions. As DWI identifies the biologic characteris-
tics of tissue, we expected that DWI would provide more useful information for
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Ddetecting breast tumors (1). We also hypothesized that
DWI has a topographic role, and it may replace the T1-
and T2-weighted imaging, for the detection of breast
tumors. We have also discussed the possibility of DWI
replacing dynamic-enhanced imaging if the latter is
contraindicated because of a patient’s allergy and/or the
expense of contrast media (5). The apparent diffusion
coefficient (ADC) values are measured to estimate the
degree of diffusion (1). Some authors have reported lower
ADC values for breast cancer compared with normal
fibroglandular tissue (2 5). Therefore, we have previously
discussed the usefulness of ADC values for detecting breast
cancer (2 5). 
To demonstrate the role of the DWI, we analyzed the
ability of each pulse sequences to detect breast lesions (the
T1-, T2-, DWI and dynamic contrast-enhanced MR
images), and we then analyzed the ADCs values of both
malignant and benign breast lesions and the normal fibrog-
landular tissue. 
MATERIALS AND METHODS
Subjects
This study includes 41 women (mean age: 53.1 years,
age range: 30 70 years) who underwent breast MRI from
June 9, 2005 to September 21, 2005 because of suspicious
mammographic or ultrasonographic abnormalities. Sixty-
five pathologically-proven breast lesions were detected on
the dynamic contrast-enhanced imaging. Fifty-six lesions
were confirmed from the surgically excised specimens and
these specimens were excised via modified radical mastec-
tomy or lumpectomy, and nine lesions were confirmed
from core needle biopsy.
Histopathologic Data 
Nine of 65 lesions were not detected on DWI and all of
the nine lesions were confirmed to be invasive ductal
carcinoma. Fifty-six of the 65 lesions were detected on
DWI. There were 52 malignant lesions, including 43
invasive ductal carcinomas, one mucinous carcinoma, one
mixed infiltrative and mucinous carcinoma, and seven
DCIS. There were four benign lesions, including one
fibroadenoma, one epidermal inclusion cyst and two cases
of fibrocystic disease. The mean diameter of the breast
lesions was 2.46 cm with a range from 0.6 cm to 13.1 cm.
MRI Protocol
The images were acquired with a 1.5-T scanner (GE
Signa Excite Twin Speed, GE Medical Systems,
Milwaukee, WI). To minimize the respiratory motion
artifacts, the patients were placed in the prone position and
MRI was performed using the following sequences: sagittal
fat-suppressed fast spin-echo T2-weighted imaging
(TR/TE= 4000/85, a flip angle of 90 , 30 slices with a field
of view [FOV] of 240 mm, a matrix of 256 224, 2
number of excitation [NEX] and a 3 mm section thickness
with a 0.1 mm intersection gap, an acquisition time of 2
minutes 56 seconds); the axial DWI with single-shot echo-
planar imaging (EPI) (b value = 0 and 1000 second/mm
2,
TR/TE= 6000/75, a FOV of 360 mm, a matrix of 128
128, 2 NEX, a 4 mm section thickness with a 1 mm
intersection gap, an acquisition time of 1 minute 30
seconds); and the pre- and post-contrast axial spin-echo
T1-weighted imaging with TR/TE = 625/12, a flip angle of
90 , 31 slices with a FOV of 300 mm, a matrix of 256
192, 1.5 NEX and an acquisition time of 3 minutes 60
seconds. After DWI in the axial plane, a postcontrast
sagittal T1-weighted three-dimensional, fat-suppressed, fast
gradient spoiled sequence (TR/TE = 6.2/3.1, a flip angle of
10 , 2.6 mm section thickness, an acquisition time of 1
minute 31 seconds) was obtained before and 0, 91, 182,
273, 364 and 455 seconds after a rapid bolus injection of
0.1 mmol/kg body weight of Gd-DTPA (Magnevist,
Schering, Berlin, Germany). The subtraction images were
obtained by subtracting the precontrast images from the
six series of post-contrast images on a pixel-by-pixel basis.
We evaluated the breast lesions with using the T1- and T2-
weighted imaging and the post-contrast T1-weighted, fat-
suppressed, fast gradient spoiled sequence with maximal
intensity projection (MIP). The computed mean ADCs of
the breast lesions were then correlated.
Comparing the Detectability of Breast Tumors on
Diffusion Weighted Imaging with that of the T1- and
T2-weighted Imaging
Three radiologists separately counted the number of the
breast lesions on the T1- and T2-weighted imaging, the
DWI and the dynamic-enhanced imaging. We used
dynamic-enhanced imaging as a reference for detecting
tumor at the time of evaluation. On the T1- and T2-
weighted image, the regions were selected as being identi-
fiable compared to the normal fibroglandular tissue. The
relative percentage of detected tumor was calculated for
the T1- and T2-weighted imaging and the DWI. Finally, we
compared the detectability of breast tumors on each pulse
sequence.
Diffusion Image Acquisition and Apparent Diffusion
Coefficients Analysis
Diffusion weighted imaging was obtained in each of the
x, y and z axes. The ADC was calculated according to
ADC = (1/b2-b1) ln (S2/S1), where S1 and S2 are the
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with different gradient factors (b values of 0 and 1000
s/mm
2). The ADC distribution was demonstrated on an
axial ADC color map. The regions selected as being clearly
identifiable had high-signal intensity on the DWI, yet we
avoided the region of high signal intensity on the T2
weighted image to exclude the T2 shine-through effect.
The ROIs were always placed within the actual mass, and
the diameter of the ROI was 10  2 mm
2. As a reference,
we used the fibroglandular tissue that appeared as
homogeneous signal intensity on both the ADC map and
the T1-weighted images. The ADC values were automati-
cally measured by drawing the ROIs. One radiologist
calculated the ADC values twice, along with the change of
location, and then she averaged these values.
To determine the ADC values of the breast tumor and
normal fibroglandular tissue, we obtained images of 56
breast lesions on DWI and we measured the ADC values
of each breast lesion. According to the histopathologic
results, we categorized the breast tumors into three groups,
i.e., invasive ductal carcinoma, DCIS and benign lesions,
and the ADC values were then averaged. We excluded the
non-invasive ductal carcinomas such as mucinous
carcinoma and the mixed infiltrative and mucinous
carcinoma because the samples’ sizes were too small. We
also compared the ADC values among the three groups
and the normal fibroglandular tissue.
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Fig. 1. A 69-year-old woman with bilateral invasive ductal carcinoma. 
A. The axial T1-weighted image shows multiple lobular homogeneous iso-signal intensity masses in both breasts.
B. The maximum-intensity projection of the subtraction image shows multiple enhancing masses in both breasts (thin white arrows and
arrowhead).
C. The axial diffusion weighted image shows multiple high-signal intensity masses in both breasts (thin white arrows), but tiny multicen-
tric lesions are not detected in the left breast (white arrowhead). The apparent difusion coefficient value of the right breast tumor was
0.94 10
3 mm
2/second and that of the left breast tumor was 0.84 10
3 mm
2/second.
D. The sagittal dynamic-enhanced T1-weighted gradient-echo substraction image of the first postcontrast acquisition shows multiple,
heterogeneous, rim-enhancing masses in both breasts (thin white arrows and white arrowhead). The left side of this image represents
the right breast and the right one represents the left breast. A tiny multicentric lesion is extremely well visualized in the left breast (white
arrowhead).
CDStatistics
T-tests were used for analyzing the differences of the
mean ADC values of the invasive ductal carcinoma, DCIS
and normal fibroglandular tissue. For comparison of the
small groups, the Mann-Whitney test was used to compare
the mean ADC values between the benign breast lesions
and the normal breast parenchyma.
RESULTS
Comparing the Detectability of Breast Tumors on
Diffusion Weighted Images with the that of the T1-
and T2-weighted Images
Sixty-five enhancing lesions were detected on the
dynamic contrast-enhanced images. Fifty-six lesions were
detected on DWI (a detectability rate of 86%). The T1-
and T2-weighted imaging detected 62% (40/65) and 75%
(49/65) of the lesions, respectively (Table 1). 
Nine of 65 enhancing lesions were not detected on DWI
(14%). Eight of these nine lesions were confirmed to be
daughter nodules of the malignant lesions (Fig. 1), and one
of the nine lesions was not visualized due to technical
problems.
Diffusion-Weighted Imaging for Breast Tumors
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Fig. 2. A 53-year-old woman with ductal carcinoma in situ.
A. The axial T1-weighted image shows segmentally distributed, asymmetric, iso-signal intensity, non-mass lesion in the left breast. 
B. The maximal intensity projection of a subtraction image shows heterogeneous clumpy enhancement in the left breast. 
C. The diffusion-weighted image shows the main lesion to be a high-signal intensity lesion.
D. The axial plane apparent diffusion coefficient map shows a mixed green and yellow area and the apparent diffusion coefficient value
of this breast tumor was 1.43 10
3 mm
2/second.
CD
Table 1. The Tumors Detected on Each Pulse Sequence out
of 65 Tumors that were seen on the Contrast
Enhanced Images
Detection Number (Rate %)
T1 40 / 65 (61.5%)
T2 49 / 65 (75.4%)
Diffusion weight image 56 / 65 (86.2%)Comparing the ADC Values of the Invasive Ductal
Carcinoma, DCIS, the Benign Lesions and the Normal
Fibroglandular Tissue
The mean ADC value of each type of lesion was invasive
ductal carcinoma: 0.89  0.18 10
3mm
2/second, DCIS:
1.17  0.18 10
3mm
2/second, benign lesions: 1.41 
0.56 10
3mm
2/second and normal breast parenchyma:
1.51  0.29 10
3mm
2/second (Table 2, Figs. 1 3). We
excluded the ADC value of noninvasive ductal carcinomas
such as one mucinous carcinoma and the one mixed
infiltrative and mucinous carcinoma. The mean ADCs of
the invasive ductal carcinoma and DCIS were significantly
lower than that of the normal fibroglandular tissue (p <
0.05). Also, the mean ADC of the DCIS was statistically
higher than that of the invasive ductal carcinoma (p <
0.05). In addition, the difference of the mean ADC values
between invasive ductal carcinoma and the benign breast
lesions was significant (p < 0.05) according to the Mann-
Whitney test.
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Fig. 3. A 41-year-old woman with fibroadenoma that was confirmed by core-needle biopsy. 
A. The axial T1-weighted image shows a circumscribed oval iso-signal intensity mass in the right breast.
B. The maximal intensity projection of the subtraction image shows homogeneous enhancement in the right breast. A nonspecific small
enhancing nodule is also seen in the left breast. This left nodule showed typical benign features on the breast USG (not shown), so we
did not perform core-needle biopsy.
C. The diffusion-weighted image shows the mass to be a high-signal intensity lesion in the right breast. 
D. The axial plane apparent diffusion coefficient map shows the mixed yellow and red area, and the apparent diffusion coefficient value
of this tumor was 1.63 10
3 mm
2/second.
CD
Table 2. The Distribution of the ADC Values for IDC, DCIS,
Benign Lesions and Normal Fibroglandular Tissue
N ADC Values (10
3 mm
2/second)
IDC 43 0.89  0.18
DCIS 7 1.17  0.18
Benign lesions 4 1.41  0.56
Fibroglandular tissue 41 1.51  0.29
Note. ADC = apparent diffusion coefficient, IDC = invasive ductal 
carcinoma, DCIS = ductal carcinoma in situDISCUSSION
Breast MRI is the widely accepted diagnostic approach
for evaluating the breast (11). To improve the sensitivity of
detecting breast cancer, several diverse techniques are
used for breast MRI (11). In particular, dynamic-enhanced
MRI provides for evaluating multiple foci of carcinoma in
the breast and it displays extremely high sensitivity for
identifying breast cancer (11, 12, 14 16). However,
dynamic-enhanced breast MRI has some disadvantages
such as being time-consuming and costly, the possible side
effects of the contrast media and the relative low
specificity compared to mammography and ultrasonogra-
phy (11, 12, 14 16).
Generally in biologic tissues, microscopic motion
includes both the molecular diffusion of water and the
blood microcirculation in the capillary network, and both
diffusion and perfusion affect the ADC values (1, 4, 5).
Because of the extent of microvessels in malignant breast
tumor, the ADC value can be strongly affected by
perfusion when the b value is small (1, 4, 5). A previous
report insisted that b-values less than 750 s/mm
2 are most
effective for detecting breast tumors (5). However, we
used single-shot EPI with a higher b-value (1,000 s/mm
2) so
we could obtain diffusion effects without any significant
image distortion (1, 3, 5).
The conventional T1- and T2-weighted images are
routinely obtained for performing breast MRI before the
contrast-enhanced MRIs are taken. Until now, the useful-
ness of the conventional T1- and T2-weighted images has
been limited because small lesion is not detected in dense
breast parenchyma and there is relatively low contrast
resolution between the fibroglandular tissue and the breast
lesion (13). In our study, DWI showed higher detectability
for breast tumors than the T1- and T2-weighted images,
although it showed lower detectability for breast tumors
than the dynamic contrast-enhanced images. 
In our study, out of the nine lesions that were not
detected on DWI, eight were found to be daughter nodules
of breast cancer. The mean size of these daughter nodules
was 0.55 cm in diameter (range: 0.4 to 0.8 cm). A previous
report demonstrated that nodules less than 1.0 cm in
diameter are not detectable on DWI (4). One remaining
nodule of the nine lesions was not detected due to
chemical shift artifact, despite its relatively large size (1.4
cm), because the chemical shift artifact caused incorrect
information about the lesion’s location. Therefore, DWI
will not perfectly replace contrast-enhanced imaging;
however, DWI is a better method for detecting breast
tumors compared to T1- and T2-weighted imaging if
contrast-enhanced imaging is contraindicated (17, 18).
Several studies have measured the ADCs of breast
lesions with using DWI (2 5). The data from these studies
has shown discrepancies in the ADC values along the b
values. For example, the mean ADCs of the malignant
lesions were 1.60  0.36  10
3 mm
2/second using b =
400 by Sinha et al. (3), 1.22  0.19  10
3 mm
2/second
using b = 700 by Kinoshita et al. (4), 1.12  0.24  10
3
mm
2/second using b = 750 by Woodhams et al. (5), and
0.97  0.20  10
3 mm
2/second using b = 1,000 by Guo
et al. (2). The reason for these discrepancies can be
explained by the fact that the ADCs were determined with
using linear regression analysis and analysis of the natural
log of the signal intensity versus the gradient factor (b) (1,
6). Our results show that the mean ADC of a malignant
lesion is 0.89  0.18  10
3 mm
2/second, which is well
correlated with the above-mentioned results. We
recommend that the ADC value of breast lesions be
compared to that of normal fibroglandular tissue because
the ADC value was variable according to the gradient
factor. Our results show that the mean ADCs of invasive
ductal carcinoma and DCIS are significantly lower than
that of normal fibroglandular tissue (p < 0.05). 
Our study has some limitations. First, the number on the
benign lesions was very small to make comparison with
malignant lesions. We usually perform DWI for the
purpose of preoperatively evaluating suspected breast
cancer. Therefore, we could not obtain a sufficient number
of benign breast lesions. Previous reports have stated that
the diffusion imaging is useful to differentiate malignant
breast lesion from benign lesion (2, 4). Secondly, we could
only perform non-parameter testing on the normal fibrog-
landular tissue distribution. Despite that we attempted to
obtain the ADC values in the normal fibroglandular tissue,
some regions were mixed up with the breast tumors, and
this was especially true for the intraductal spread of breast
lesions. Thirdly, we could not detect daughter nodules, and
especially those that were less than 1.0 cm in diameter. In
our study, we used a slice thickness of 1 cm for DWI, but
we used a slice thickness of 3 mm for the dynamic
contrast-enhanced imaging (4). 
In conclusion, DWI is a better method for detecting
breast tumors than either T1- or T2-weighted imaging, but
DWI should be performed in conjunction with contrast-
enhanced MRI because it is evident that small breast
lesions are not seen on DWI. In addition, the DWI is an
effective screening technique. We can obtain DWI with a
one-minute scan time. The ADC value is useful to differen-
tiate malignant breast lesion from normal breast fibroglan-
dular tissue. Yet the ADC value is variable according to
the gradient factor, and it should be compared with that of
Diffusion-Weighted Imaging for Breast Tumors
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